2m 2m 2m 2m 2m 2m 2m
NEXGEL (NXGL)
NASDAQ
$0.54-$0.07 (-12.07%)
Price as of Jun 23, 2026 7:05 PM EDT- $5.6MMarket Cap
- -74.12%1-Year Change
- Medical Instruments & SuppliesIndustry
NEXGEL (NXGL)
$0.54-$0.07 (-12.07%)
Annual
Quarterly
12/31/2025 | 12/31/2024 | 12/31/2023 | 12/31/2022 | ||
|---|---|---|---|---|---|
Income Statement | |||||
Total Operating Revenue | 11.4M +31.46% | 8.7M +112.47% | 4.1M +99.66% | 2.0M +32.04% | |
Cost of Revenue | 6.9M +16.36% | 5.9M +71.18% | 3.5M +93.64% | 1.8M +16.21% | |
Gross Profit | 4.5M +64.08% | 2.7M +343.94% | 619,000 +141.80% | 256,000 +2,744.44% | |
Sales and Marketing Expense | 7.9M +26.27% | 6.2M +55.87% | 4.0M +23.35% | 3.2M +27.04% | |
Research and Development Expense | N/A N/A | N/A N/A | -103,000 -71.93% | -367,000 +1,083.87% | |
Depreciation and Amortization Expense | 450,000 +3.21% | 436,000 +92.92% | 226,000 +101.79% | 112,000 -0.88% | |
Total Operating Expenses | 7.9M +24.74% | 6.3M +53.86% | 4.1M +13.65% | 3.6M +39.74% | |
Operating Profit | -3.4M -5.68% | -3.6M +2.21% | -3.5M +3.85% | -3.3M +30.27% | |
Interest Income | 286,000 +191.84% | 98,000 +415.79% | 19,000 +533.33% | 3,000 N/A | |
Interest Expense | N/A N/A | N/A N/A | -15,000 N/A | N/A N/A | |
Interest Income and Expense and Net | 286,000 +191.84% | 98,000 +2,350.00% | 4,000 +33.33% | 3,000 N/A | |
Total Nonoperating Income and Expense | 459,000 +404.40% | 91,000 -68.51% | 289,000 +120.67% | -1.4M -19.66% | |
Income before Taxes | -2.9M -16.46% | -3.5M +8.63% | -3.2M -4.78% | -3.3M +30.27% | |
Income Taxes | N/A N/A | N/A N/A | N/A N/A | 0 N/A | |
Extraordinary Items | N/A N/A | N/A N/A | N/A N/A | 0 N/A | |
Net Income | -3.0M -8.56% | -3.3M +3.93% | -3.2M -33.48% | -4.7M +10.12% | |
Net Income from Continuing Operations Applicable to Common | -2.9M -16.46% | -3.5M +8.63% | -3.2M -32.83% | -4.7M +10.12% | |
Basic EPS and Net Income | -0.38 -24.00% | -0.50 -10.71% | -0.56 -34.12% | -0.85 -41.38% | |
Diluted EPS and Net Income | -0.38 -24.00% | -0.50 -10.71% | -0.56 -34.12% | -0.85 -41.38% | |
Basic Weighted Average Shares | 7.9M +20.62% | 6.5M +14.81% | 5.7M +1.74% | 5.6M +87.08% | |
Diluted Weighted Average Shares | 7.9M +20.62% | 6.5M +14.81% | 5.7M +1.74% | 5.6M +87.08% | |
Balance Sheet | |||||
Cash and Cash Equivalents | 317,000 -82.46% | 1.8M -33.07% | 2.7M +145.23% | 1.1M -91.75% | |
Short-Term Investments | N/A N/A | N/A N/A | N/A N/A | 5.5M N/A | |
Cash and Cash Equivalents and Short-Term Investments | 317,000 -82.46% | 1.8M -33.07% | 2.7M -59.15% | 6.6M -50.49% | |
Total Current Assets | 4.3M -15.17% | 5.1M +1.23% | 5.1M -32.68% | 7.5M -46.11% | |
Accumulated Depreciation | 1.4M +31.00% | 1.0M +43.94% | 726,000 +22.22% | 594,000 +20.00% | |
Property and Plant and Equipment and Net | 2.0M -11.58% | 2.2M +47.50% | 1.5M +107.91% | 721,000 -0.28% | |
Total Long-Term Assets | 95,000 -95.70% | 2.2M +2,227.37% | 95,000 +50.79% | 63,000 0.00% | |
Total Assets | 10.5M -4.75% | 11.0M +10.33% | 10.0M -3.88% | 10.4M -39.02% | |
Income Taxes Payable | N/A N/A | N/A N/A | N/A N/A | 52,000 N/A | |
Total Short-Term Debt | 99,000 +2.06% | 97,000 +21.25% | 80,000 N/A | N/A N/A | |
Total Current Liabilities | 3.0M +19.68% | 2.5M -3.10% | 2.5M +196.74% | 859,000 -70.26% | |
Total Long-Term Debt | 489,000 -16.84% | 588,000 +14.62% | 513,000 +91.42% | 268,000 -81.96% | |
Total Long-Term Liabilities | 2.4M +11.57% | 2.1M -5.09% | 2.2M +20.37% | 1.9M +6.71% | |
Total Liabilities | 5.6M +13.60% | 4.9M +2.38% | 4.8M +76.07% | 2.7M -44.47% | |
Retained Earnings | -21.0M +16.67% | -18.0M +22.30% | -14.7M +27.31% | -11.6M +69.67% | |
Total Stockholders Equity | 4.5M -22.52% | 5.8M +22.53% | 4.7M -38.50% | 7.6M -36.81% | |
Total Shares Outstanding | 8.1M +6.61% | 7.6M +33.03% | 5.7M +2.94% | 5.6M +0.10% | |
Cash Flow | |||||
Cash from Operating Activities | -1.3M -66.10% | -3.9M +19.50% | -3.2M +8.16% | -3.0M +8.68% | |
Capital Expenditures | 68,000 -84.65% | 443,000 -36.35% | 696,000 +625.00% | 96,000 -64.31% | |
Cash from Investing Activities | -68,000 -91.23% | -775,000 -117.39% | 4.5M +179.64% | -5.6M +1,979.93% | |
Dividends Paid | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Cash from Financing Activities | 630,000 -83.20% | 3.7M +889.18% | 379,000 +110.35% | -3.7M -122.41% | |
Financials Ratio | |||||
Gross Margin | 39.48% +24.82% | 31.63% +108.94% | 15.14% +21.11% | 12.50% +2,054.06% | |
Operating Margin | -29.35% -28.25% | -40.91% -51.89% | -85.03% -47.98% | -163.48% -1.34% | |
Return on Assets | -27.98% -10.72% | -31.34% +0.82% | -31.09% -10.47% | -34.72% -22.51% | |
Return on Equity | -58.74% -6.43% | -62.78% +22.64% | -51.19% +6.36% | -48.13% -32.13% | |
Revenue Growth | 31.46% -72.03% | 112.47% +12.86% | 99.66% +211.01% | 32.04% -75.37% | |
Current Ratio | 1.47 -29.12% | 2.07 +4.46% | 1.98 -77.31% | 8.74 +81.17% | |
Cash Ratio | 0.11 -85.35% | 0.73 -30.93% | 1.06 -17.36% | 1.28 -72.27% | |
Debt-to-Equity Ratio | 0.13 +10.84% | 0.12 -5.78% | 0.13 N/A | N/A N/A | |
Debt-to-Assets Ratio | 0.06 -9.94% | 0.06 +4.70% | 0.06 N/A | N/A N/A | |
Earnings & Revenue History
Debt-to-Assets
Cash Flow